|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
9 months to Dec 31, 2021
|
|
|---|---|---|---|
| Net income | |||
| Adjustments to reconcile net income to net cash used in operating activities: | |||
| Investment income earned on Trust Account | |||
| Unrealized gain on investments held in Trust Account | |||
| Investment income from Trust Account | |||
| Unrealized gain on investments held in Trust Account | |||
| Reduction of deferred underwriter fee payable | |||
| Change in fair value of warrant liabilities | |||
| Expenses paid by Sponsor through promissory note and advances | |||
| Transaction costs allocated to warrant liabilities | |||
| Forgiveness of debt | |||
| Prepaid expenses | |||
| Accrued expenses | |||
| Net cash used in operating activities | |||
| Cash Flows from Investing Activities: | |||
| Investment of cash in Trust Account | |||
| Investment of cash in Trust Account | |||
| Cash withdrawn from Trust Account in connection with redemption | |||
| Net cash provided by investing activities | |||
| Proceeds from sale of Units, net of underwriting discounts paid | |||
| Proceeds from sale of Private Placement Warrants | |||
| Repayment of advances from related party | |||
| Repayment of promissory note – Sponsor | |||
| Offering costs paid | |||
| Proceeds from subscription agreement liability | |||
| Proceeds from promissory note - related party | |||
| Payments for redemptions of Class A ordinary shares | |||
| Net cash used in financing activities | |||
| Net Change in Cash | |||
| Cash – Beginning | |||
| Cash – Ending | |||
| Non-Cash Investing and Financing Activities: | |||
| Offering costs paid by Sponsor in exchange for issuance of Class B ordinary shares | |||
| Offering costs included in promissory note – Sponsor | |||
| Offering costs included in due to Sponsor | |||
| Deferred underwriting commissions | |||
| Remeasurement of Class A ordinary shares to redemption value | |||
| Reduction of deferred underwriter fees | |||
| Debt forgiven by initial sponsor PFTA I LP |
Loading...
